Larger prospective studies are necessary to confirm the potential role of copeptin in the early identification of subjects with polyuria not secondary to CDI both among individuals with acromegaly and more generally in subjects with pituitary lesion undergoing neurosurgery. This evidence concerns the gene AVP and acromegaly.